Nyra Medical to Highlight First-in-Human Clinical Insights Through Presentations at EuroPCR
Nyra Medical will present at EuroPCR, showcasing insights from its First-in-Human clinical study and highlighting the CARLEN™ System. CEO Lori Chmura will address key lessons learned, emphasizing the company’s clinical validation and strategic growth in the medtech space.
ATLANTA, May 14, 2026 /PRNewswire/ — Nyra Medical, a leading innovator in structural heart therapies, today announced its participation in the upcoming EuroPCR meeting, where the company will be featured in three key presentations underscoring continued its growing clinical validation,…